|
Register
for e-mail alerts
On The Horizon Future Medicines, Sugammadex - April 2008
Click
on the menu function to your right to view
the New Medicines Scheme publications. PDF
publications are best viewed using Adobe
Reader 7.0.
NOTE:
Every effort is made to ensure that the information
contained in the NPC website is accurate and
up to date at the time of press. Please be
aware that information about medicines and
therapeutics will change over time, and that
information in the materials listed below
may not be current after the initial date
of publication. Please take note of the publication
date and seek further advice if in any doubt
about the currency of the information. Only
those New Medicines Scheme publications produced
from 2001 onwards are included on this website.
The New Medicines Scheme at the National Prescribing
Centre (NPC) is a well-established programme
for providing advance information to the NHS
to support the managed introduction of key
new medicines.
Products
are selected for assessment and prioritisation
within the New Medicines Scheme 18 to 24 months
before they are likely to be marketed. The
selection process is supported by the work
of an NPC managed Prioritisation Group, which
applies a set of criteria to take into account
the potential clinical, financial and service
delivery implications of new medicines and
new indications for existing medicines.
We regularly review our outputs and their
delivery to ensure our work continues to meet
the needs of key NHS managers, budget holders,
and others in local health economies who require
timely access to concise, evaluated information
on new medicines. Our current portfolio consists
of the publications below, which are all available
for viewing and download from our NHSnet website
(www.npc.nhs.uk).
NHSnet connection is required to access these
publications, and you can click
here to register for e-mail alerts to
be informed when new publications become available.
On
the Horizon - Future Medicines bulletins.
These bulletins sensitise the NHS to significant
new medicines in order to facilitate local
advance planning and more effective, timely
managed introduction. They are published online
approximately six months pre-launch for medicines
where no NICE guidance is planned near launch.
On
the Horizon - Post Launch Update bulletins.
These are only produced when significant additional
information has emerged since the publication
of the related On the Horizon - Future
Medicine bulletins. Published online
within six weeks of a key product being marketed
where no NICE guidance is planned near launch,
they include any additional clinical data
that became available in the preceding six
months, price, range of presentations, relevant
marketing / promotional plans. These publications
were previously called On the Horizon
Rapid Reviews.
On
the Horizon Newsletter. These generic,
two-sided A4 newsletters provide brief news
items containing advance, or updated information,
on a range of products that may come to market
within the following two years. These are
published online and are also posted out in
hard copy twice a year to a core audience
of key local decision-makers.
New
Drugs in Clinical Development Monographs.
These will only be produced for key products
that have been suitably prioritised, and scheduled
into the NICE programme such that they will
be covered by NICE guidance at or around the
time of their launch. Online publication will
be at least nine to 12 months before product
launch.
On
the Horizon - Future Medicine and On
the Horizon - Post Launch Update bulletins
are produced in conjunction with Wessex Drug
and Medicines Information Centre. New
Drugs in Clinical Development monographs
are produced by working with a consortium
of regional MI centres (represented by a specified
lead Centre).
Planning
Ahead for key new medicines - September 2007 This resource
is designed to inform NHS planning for managing in fifteen
new medicines/NICE technology appraisals that may be
due in the next 18 months or so, and where the clinical
and/or resource impact may be sufficiently high to require
a local impact assessment and plan of introduction.
We are piloting a new electronic publication
called New Medicine Alert. This will
be published online when a significant new
medicine, which the NPC has normally covered
previously in an On the Horizon - Future
Medicine bulletin, successfully reaches
the market, and where no NICE guidance is
planned near or at market launch. The aim
of this publication is to provide a brief
summary of relevant information about a selected
medicine at the time of its launch that can
be used to inform practitioners, commissioners
and others in the local health economy of
key relevant issues.
|
